ArticleBioMed research international2025
Introducing the Event-Adjusted Rank Sum (EARS) Test: A Simple Approach to Survival Analysis Independent of Proportional Hazards.
Article in BioMed research international, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Introducing the Event-Adjusted Rank Sum (EARS) Test: A Simple Approach to Survival Analysis Independent of Proportional Hazards.BioMed research international · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Survival analyses often violate the proportional hazards (PH) assumption, compromising the validity of widely used statistical tests such as the log-rank test and Cox regression. To address this limitation, we introduce the event-adjusted rank sum (EARS) test, a nonparametric method designed to provide robust time-to-event data analysis without relying on PH. Materials and Methods: The EARS test adjusts survival times by dividing each event time by the proportion of events within its respective group. These adjusted survival times are then compared using the Kruskal-Wallis test. To account for censoring, the resulting Results: In simulation studies, the EARS and log-rank tests agreed in 96.6% of cases. Under the null hypothesis, the EARS test demonstrated a Type I error rate of 2% across two to five groups, slightly higher than the log-rank test's 1%. Power analyses revealed that EARS detected true differences in 63% of cases compared to 68% for the log-rank test. In 1000 datasets violating the PH assumption, EARS identified significant differences in 94.4% of cases versus 98.0% for RMST, with both methods agreeing 96.4% of the time on null hypothesis rejection. Analyses of clinical cohorts further confirmed the reliability of the EARS test, showing consistent alignment with established tests in most scenarios. Conclusion: The EARS test offers a simple, nonparametric alternative for survival analysis that remains reliable across diverse conditions and varying censoring distributions. Its accessibility and robust performance make it a valuable tool for researchers and clinicians, especially in settings where the PH assumption is violated or advanced statistical software is unavailable. An R package implementing the EARS test is openly available.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.